Skip to main content
OpenTrials

Clinical trial condition

Pancreatic Diseases

Explore clinical trials studying Pancreatic Diseases. Study availability and eligibility vary by location and protocol.

4,391 public trials 843 recruiting studies
Refine in advanced search Browse all conditions

Pancreatic Diseases trial results

Completed

Veliparib in Treating Patients With Malignant Solid Tumors That Do Not Respond to Previous Therapy

NCT00892736

Conditions
Adnexal Diseases, BRCA1 Mutation Carrier, BRCA2 Mutation Carrier, +48 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • City of Hope South Pasadena South Pasadena, California, United States
View Trial Details
Completed

A Study Comparing the Efficacy and Tolerability of Tobrineb®/Actitob®/Bramitob® Versus TOBI®

NCT00885365

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +5 more
Locations
  • Centrum pro cystickou fibrosu, Pediatricka klinika UK 2.LF, Fakultní nemocnice v Motole Prague, Czechia
  • CHR Clemenceau Caen, France
  • Hopital Arnaud de Villeneuve, Clinique des maladies respiratoires Montpellier, France
  • Hopital Necker Paris, France
View all 44 locations
View Trial Details
Completed

A Study Evaluating the Safety and Pharmacokinetics of DMUC4064A in Participants With Platinum-Resistant Ovarian Cancer or Unresectable Pancreatic Cancer

NCT02146313

Conditions
Adnexal Diseases, Digestive System Diseases, Digestive System Neoplasms, +16 more
Locations
  • Florida Cancer Specialists - Sarasota (North Catttlemen Rd) Sarasota, Florida, United States
  • Massachusetts General Hospital. Boston, Massachusetts, United States
  • Dana Farber Cancer Inst. Boston, Massachusetts, United States
  • Hackensack Univ Med Ctr Hackensack, New Jersey, United States
View Trial Details
Completed

A Phase 3 Study to Evaluate the Efficacy and Safety of Ivacaftor and VX-661 in Combination With Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, Heterozygous for the F508del-cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mutation

NCT02392234

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +5 more
Locations
  • Birmingham, Alabama, United States
  • Phoenix, Arizona, United States
  • Tucson, Arizona, United States
  • Long Beach, California, United States
View all 93 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of VX-661 in Combination With Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, Heterozygous for the F508del-CFTR Mutation

NCT02516410

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +5 more
Locations
  • Birmingham, Alabama, United States
  • La Jolla, California, United States
  • Los Angeles, California, United States
  • Denver, Colorado, United States
View all 41 locations
View Trial Details
Completed

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of VX-661 in Combination With Ivacaftor

NCT02347657

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +5 more
Locations
  • Little Rock, Arkansas, United States
  • Long Beach, California, United States
  • Denver, Colorado, United States
  • Orlando, Florida, United States
View all 74 locations
View Trial Details

Related conditions